Elevated remnant cholesterol increase 6-year T2DM onset risk.

[1]  Shuo Yang,et al.  Remnant Cholesterol is an Independent Predictor of New-Onset Diabetes: A Single-Center Cohort Study , 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

[2]  M. Connelly,et al.  Triglyceride-rich lipoprotein and LDL particle subfractions and their association with incident type 2 diabetes: the PREVEND study , 2021, Cardiovascular Diabetology.

[3]  Ming Zhang,et al.  Cohort Profile: The Rural Chinese Cohort Study. , 2020, International journal of epidemiology.

[4]  C. Bonfiglio,et al.  Remnant cholesterol as a risk factor for cardiovascular, cancer or other causes mortality: A competing risks analysis. , 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[5]  I. Kazemi,et al.  Prevalence and predictors of prediabetes and its coexistence with high blood pressure in first-degree relatives of patients with type 2 diabetes: A 9-year cohort study , 2020, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[6]  A. Jaffe,et al.  A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia. , 2020, JAMA cardiology.

[7]  M. Sabatine,et al.  2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. , 2019, European heart journal.

[8]  B. Nordestgaard,et al.  Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population , 2019, Annals of neurology.

[9]  Frank B. Hu,et al.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications , 2018, Nature Reviews Endocrinology.

[10]  B. Nordestgaard,et al.  Remnant Cholesterol and Myocardial Infarction in Normal Weight, Overweight, and Obese Individuals from the Copenhagen General Population Study. , 2018, Clinical chemistry.

[11]  Jian-Min Yuan,et al.  Association between the ratio of triglyceride to high‐density lipoprotein cholesterol and incident type 2 diabetes in Singapore Chinese men and women , 2017, Journal of diabetes.

[12]  Hynek Pikhart,et al.  PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study , 2017, The lancet. Diabetes & endocrinology.

[13]  Szilard Voros,et al.  Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes. , 2016, The New England journal of medicine.

[14]  Sara M. Willems,et al.  Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis. , 2016, JAMA.

[15]  Wenying Yang,et al.  Standards of care for type 2 diabetes in China , 2016, Diabetes/Metabolism Research Reviews.

[16]  P. Toth.  Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease , 2016, Vascular health and risk management.

[17]  G. Maurer,et al.  Premature myocardial infarction is strongly associated with increased levels of remnant cholesterol. , 2015, Journal of clinical lipidology.

[18]  B. Nordestgaard,et al.  Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population. , 2015, Clinical chemistry.

[19]  Anne Tybjærg-Hansen,et al.  Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Blood Pressure as Mediators From Obesity to Ischemic Heart Disease , 2015, Circulation research.

[20]  A. Kwakernaak,et al.  Plasma proprotein convertase subtilisin-kexin type 9 is predominantly related to intermediate density lipoproteins. , 2014, Clinical biochemistry.

[21]  Á. Chamorro,et al.  Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients , 2014, Stroke.

[22]  B. Nordestgaard,et al.  Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. , 2014, Pharmacology & therapeutics.

[23]  B. Nordestgaard,et al.  Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation , 2013, Circulation.

[24]  B. Nordestgaard,et al.  Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. , 2013, European heart journal.

[25]  B. Nordestgaard,et al.  Remnant cholesterol as a causal risk factor for ischemic heart disease. , 2013, Journal of the American College of Cardiology.

[26]  J. Borén,et al.  Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management , 2011, European heart journal.

[27]  J. Danesh,et al.  Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.

[28]  Shah Ebrahim,et al.  Fasting Blood Glucose and the Risk of Stroke and Myocardial Infarction , 2009, Circulation.

[29]  Alyssa H. Hasty,et al.  Direct Effect of Cholesterol on Insulin Secretion , 2007, Diabetes.

[30]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[31]  J. Breslow,et al.  Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  H. Shin,et al.  Remnant Lipoprotein Particles Induce Apoptosis in Endothelial Cells by NAD(P)H Oxidase–Mediated Production of Superoxide and Cytokines via Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Activation: Prevention by Cilostazol , 2004, Circulation.

[33]  M. Sekiya,et al.  The close relationship between postprandial remnant metabolism and insulin resistance. , 2004, Atherosclerosis.

[34]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[35]  S. Takagi,et al.  Relationship between insulin-resistance and remnant-like particle cholesterol. , 2002, Atherosclerosis.

[36]  P. Wilson,et al.  Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study. , 2002, Diabetes care.

[37]  T. Taniguchi,et al.  Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. , 1999, Diabetes care.

[38]  K. Nakajima,et al.  Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages. , 1994, Journal of atherosclerosis and thrombosis.